Beta Drugs Limited — Others, 26-12-2024: Shareholders meeting

Beta Drugs Limited held an Extraordinary General Meeting (EGM) where key decisions were made, including the adoption of restated Articles of Association and the appointment of Mr. Sanjay Sehgal as an Independent Director for a five-year term. Additionally, Mr. Ajay Mahipal was appointed as a Non-Executive Director. The meeting emphasized the electronic voting process, ensuring transparency in shareholder decision-making. This restructuring could strengthen governance and enhance investor confidence, reflecting a positive outlook for future operations. Overall, these developments may present opportunities for Alpha Drugs, as it aligns its governance frameworks with strategic growth objectives.